mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells-Reference-Cited by-同舟云学术

mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells

Published:2016-09 Issue:9 Volume:100 Page:1898-1906
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Avila Christina L.,Zimmerer Jason M.,Elzein Steven M.,Pham Thomas A.,Abdel-Rasoul Mahmoud,Bumgardner Ginny L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference64 articles.

1. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure;Einecke;Am J Transplant,2009

2. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence;Sellares;Am J Transplant,2012

3. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure;Gaston;Transplantation,2010

4. Late and chronic antibody-mediated rejection: main barrier to long term graft survival;Sun;Clin Dev Immunol,2013

5. Hepatocyte immunology and transplantation: current status and future potential;Walker;Curr Opin Organ Transplant,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recognizing Complexity of CD8 T Cells in Transplantation;Transplantation;2024-04-19

2. Oxymatrine combined with rapamycin to attenuate acute cardiac allograft rejection;Heliyon;2024-04

3. Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies and graft outcomes in kidney transplant recipients: 12-month results from the ATHENA substudy;Frontiers in Transplantation;2023-11-21

4. CXCR5+CD8+ T Cell–Mediated Suppression of Humoral Alloimmunity and AMR in Mice Is Optimized With mTOR and Impaired With Calcineurin Inhibition;Transplantation;2023-10-24

5. Difficult-to-Treat Rejections in Kidney Transplant Recipients: Our Experience with Everolimus-Based Quadruple Maintenance Therapy;Journal of Clinical Medicine;2023-10-21